https://www.selleckchem.com/products/wnk463.html
BACKGROUND Aberrant expression of mucin-4 (MUC4) is present in a variety of human solid cancers, but the expression pattern of MUC4 and its clinical relevance in acute myeloid leukemia (AML) is unknown. We aimed to evaluate the expression level of MUC4 and explore its prognostic value in newly diagnosed adult patients with AML. METHODS Bone marrow from 70 AML patients and 26 healthy donors were obtained. MUC4 levels were quantified by Quantitative real time- PCR. Routine blood indices were measured by standard techniques. RESULTS Bone ma
Curtir
Comentario
Compartilhar
